DiaMedica Therapeutics, Inc. (DMAC)
7.24
-0.48
(-6.22%)
USD |
NASDAQ |
Mar 12, 16:00
7.35
+0.11
(+1.52%)
Pre-Market: 20:00
DiaMedica Therapeutics Market Cap : 377.04M for March 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| XOMA Royalty Corp. | 332.61M |
| Bristol Myers Squibb Co. | 120.05B |
| Avantor, Inc. | 5.388B |
| ACADIA Pharmaceuticals, Inc. | 3.626B |
| Alnylam Pharmaceuticals, Inc. | 42.07B |
Market Cap Related Metrics
| PEG Ratio | -0.3395 |
| Price to Book Value | 7.304 |
| Price | 7.24 |
| Earnings Yield | -9.91% |
| PEGY Ratio | -0.3395 |